Understanding Elis' Share Structure and Voting Rights Disclosure

Elis' Share Capital and Voting Rights Overview
In the dynamic landscape of corporate finance, understanding the structure of share capital and voting rights is critical for investors and stakeholders alike. A recent disclosure by Elis sheds light on these aspects as of a specified date. This information is essential for making informed investment decisions.
Key Figures in Share Capital
Elis has reported a total number of shares amounting to 236,664,445. Each share represents an ownership stake in the company, and this large figure highlights the company's size and market presence.
Understanding Voting Rights
In addition to the shares, it's crucial to note the total theoretical voting rights associated with those shares. For Elis, this number stands at 275,690,162. This figure accounts for the potential voting power that shareholders collectively possess in corporate decisions.
Exercisable Voting Rights
Furthermore, out of the theoretical voting rights, the number of exercisable voting rights amounts to 273,207,101. This signifies the votes that shareholders can actively use to influence corporate governance.
Importance of This Disclosure
Such disclosures are made under specific articles of the French Commercial Code, emphasizing transparency in corporate governance. It is vital for shareholders to understand their stake and influence within the company.
Where to Find More Information
Investors can find the full disclosure details on Elis' official website. Regular updates on share structure and voting rights can further aid in understanding how the company operates and how shareholder decisions are made.
Contacting Investor Relations
For those wishing to engage further with the company's management, here's how to reach out: Nicolas Buron, the Director of Investor Relations, can be contacted via phone at +33 1 75 49 98 30 or email at nicolas.buron@elis.com. Charline Lefaucheux, another point of contact in Investor Relations, is available at +33 1 75 49 98 15 or charline.lefaucheux@elis.com.
Frequently Asked Questions
What is the total number of shares for Elis?
The total number of shares for Elis is 236,664,445.
How many theoretical voting rights does Elis have?
Elis has a total of 275,690,162 theoretical voting rights.
What are exercisable voting rights?
Exercisable voting rights are the votes shareholders can actively use, which for Elis amounts to 273,207,101.
Why are these disclosures important?
These disclosures ensure transparency in corporate governance and help shareholders understand their influence within the company.
Who can I contact for more information about Elis?
Nicolas Buron and Charline Lefaucheux from the Investor Relations team can be contacted for further information.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.